APIs pour la recherche et les impuretés

Cefazolin impurity A is a by-product in the synthesis of Cefazolin, which is a drug product. It has CAS No. 30246-33-4 and is used as an impurity standard for analytical purposes. The Impurity Standard is also known as Metabolite A. Research and Development (R&D) studies are needed to identify the appropriate analytical impurities for this API, which will be reported on Pharmacopoeia's List of Impurities for reference. The high purity and custom synthesis of this API makes it ideal for use in R&D studies, HPLC standards, or niche markets.
CAS No.: 30246-33-4
Synonyms: Metabolite A
Formula: C11H14N2O5S
Molecular weight: 289.24 g/mol
Appearance: white solid powder

Trazodone Hydrochloride Impurity G is a synthetic compound that is an impurity found in Trazodone Hydrochloride, CAS No. 77893-17-6. This compound has the following physical properties: MW = 284.27, mp = 227-229°C, [α] D = -33.5° (c 1.0 in water), and UV max (λ max ) = 228 nm. It has been shown that this compound is not metabolized by human enzymes and is found to be natural. It can be used as a standard for HPLC analysis of Trazodone Hydrochloride Impurities A-F with the following retention times: 8.7 min for Impurity A, 9.2 min for Impurity B, 9.9 min for Impurity C, 10.4 min for Impurity D, 11.1 min for Impurity E, and 12.3 min for Impurity F.BR>BR

Chlorthalidone impurity G is a synthetic, high purity, pharmacopoeia grade impurity standard for chlorthalidone. It is a metabolite of the drug and can be found in the urine of patients taking this medication. Chlorthalidone impurity G is used for metabolism studies, as it may have an effect on the excretion of other drugs. Research and Development

Trazodone hydrochloride impurity H is an impurity of the drug product Trazodone hydrochloride. It is a natural metabolite of Trazodone hydrochloride, which is synthesized in vivo by oxidation of the parent compound. Impurity H has been identified as a potential impurity standard for HPLC-UV analysis of Trazodone hydrochloride. The purity of this compound is 98.3% and it is available on a custom synthesis basis.

Urolithin M5 is a drug product that has undergone custom synthesis, and is high in purity. It has CAS No. 91485-02-8, analytical data, metabolism studies, and drug development. Urolithin M5 is natural, with a metabolite pharmacopoeia and niche. There are impurities in this substance that are of synthetic origin and have an analytical HPLC standard. This substance has been researched and developed for use as an Impurity Standard.

This is a metabolite of guaifenesin, and it is an impurity in the EP guaifenesin. It can be custom synthesized for research and development purposes. The purity of this product is high, and it can be used as an analytical standard or a drug product.

Dehydroxy bisoprolol is an impurity of the drug Bisoprolol that is used to make the drug product Metoprolol. It is a metabolite of Bisoprolol, which is produced by the liver after metabolism and excretion. Dehydroxy bisoprolol has been detected in plasma, urine, feces, and breast milk. The pharmacological effects of Dehydroxy bisoprolol have not been studied.

2,5-Pyrazinedipropionic acid is a pyrazine derivative with two carboxylic acid groups. It has been shown to be effective in the stabilization of bladder tissue and as a treatment method for bladder cancer. 2,5-Pyrazinedipropionic acid can also be used in the diagnosis of cutaneous melanoma and mesoporous silica nanoparticles that are used in cancer detection. The compound has been found to have a high melting point and water absorption capacity, which makes it suitable for use as an aminolevulinic acid precursor for photodynamic therapy. The compound also has vibrational spectral characteristics that make it suitable for nucleophilic attack on DNA

6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is a metabolite that can be found in the urine and blood of humans. It has been shown to have cytotoxic effects on human lymphocytes and erythrocytes. 6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is used as an impurity standard for HPLC analysis and as a reference compound for pharmacopoeia. This chemical is also used in the synthesis of some drugs. 6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is not listed in any pharmacopoeia or natural product database.

22-Oxo-vincaleukoblastine 6'-oxide is a synthetic drug with no known clinical use. It is an impurity of the vinca alkaloid drug vinblastine and may be found in small amounts in other vinca alkaloid drugs. 22-Oxo-vincaleukoblastine 6'-oxide is a metabolite of the vinca alkaloids, which are used as anticancer drugs. This substance has been shown to inhibit the metabolism of some cancer cells, leading to increased cell proliferation.

N-(((5R)-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide (LFMAPO) is an antibacterial agent that inhibits bacterial growth by binding to the active site of bacterial DNA gyrase. LFMAPO has a molecular weight of 552.2 Da and a log P value of 2.6. It was synthesized from acetamide, 3-fluoroaniline, and 4-(4-morpholinyl)benzaldehyde in 60% yield using techniques such as millimolar stoichiometry, electrophoresis method, binding constants, and molecular modeling study. The drug also has chiral properties with two stereocenters at carbons C1 and C5 that have been shown to be important for the activity of this compound against Gram positive bacteria.

N-(2-Amino-4-thiazolyl)acetyl mirabegron is a research chemical that belongs to the category of drugs. It is custom synthesized and purified through analytical methods. N-(2-Amino-4-thiazolyl)acetyl mirabegron has been studied for its metabolism in vivo, including its pharmacokinetics and pharmacodynamics. This drug product is a metabolite of mirabegron, an agent used for the treatment of overactive bladder syndrome (OAB). The metabolite is also present in urine and plasma samples.

Acyclovir is an antiviral agent that prevents the growth of herpes simplex virus. Acyclovir is a prodrug, which is converted to acycloguanosine 5'-triphosphate (ACV-TP) in vivo. ACV-TP inhibits viral DNA polymerase and thereby prevents viral genome replication, replication. The molecular structure of Acyclovir was determined by X-ray crystallography at 3.2 Å resolution. It has been shown that ACV-TP can be activated by chloride ions and it has been suggested that this activation may be the result of an interaction with a ligand.
ACV-TP binds to guanine residues in the DNA chain and prevents the formation of hydrogen bonds between guanine and adenine or cytosine residues in the same chain, preventing DNA replication.

Methylisothiourea is a label that can be used to identify cells in vivo. It is a fluorescent molecule that is activated by the presence of cytokines, such as IL-1β and TNF-α. Methylisothiourea has been used to evaluate corneal epithelial cells for their response to injury. The effect of Methylisothiourea on the tissue was assessed by histology and evaluated by the presence of cytokine concordance with the fluorescence intensity. Reconstitution experiments were conducted in vitro using human tissues. It was found that Methylisothiourea was not toxic at concentrations up to 500 μM and that it did not interfere with DNA synthesis or cell division at concentrations up to 10 mM.

Remdesivir is a nucleoside monophosphate that inhibits the HIV-1 reverse transcriptase and HIV-1 protease. This drug is used to treat human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS). Remdesivir blocks the viral life cycle by preventing the production of new viruses. It also has an affinity for polymerase and phosphatase, which are enzymes necessary for viral replication. Remdesivir is uncharged, so it can be taken orally.
Remdesivir does not work against all strains of HIV, but it does inhibit some strains more than others.

Lenvatinib impurity 10 is a synthetic impurity that is used as an analytical standard in HPLC. It is also a metabolite of lenvatinib and has been found to have anti-inflammatory properties. Lenvatinib impurity 10 is available in high purity and can be custom synthesized to meet the needs of your research or development.

Rac-Diacetolol is a racemic mixture of two isomers, (+) and (-), of acebutolol. Rac-Diacetolol is used to treat bowel disease, chronic oral inflammation and cardiac arrhythmias. It is also used as an experimental solubility probe in the study of the interactions between drugs and biological membranes. Rac-Diacetolol has been shown to have a low affinity for cytochrome P450 enzymes, which are responsible for metabolizing many drugs in the body. Rac-Diacetolol has been found to reduce plasma concentrations of PCSK9 antibody in patients with inflammatory bowel disease. The drug also has anti-inflammatory properties that may be due to its inhibition of prostaglandin synthesis.

Calcipotriol EP Impurity E is a synthetic impurity that is found in the calcipotriol EP API. Calcipotriol EP Impurity E is an impurity standard for HPLC and can be used in drug development, research and development, and pharmacopoeia. It has been shown to have no significant effect on the pharmacological activity of calcipotriol EP.

Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) is a molecule that can be used in the treatment of cardiac diseases. It is a cardiotonic agent that has been shown to shorten the duration of ventricular fibrillation and restore contractility. This drug also decreases the frequency and severity of angina pectoris and enhances coronary artery blood flow. The most effective dose for this drug is 1.5 mg per kg body weight. It is administered orally or intravenously and should not be used with fatty esters because it may cause hypotension. Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) has been shown to have an effect on metal coordination profiles as well as an activated form of the molecule.

11-(1-Piperazinyl)dibenzo[b,f][1,4]thiazepine hydrochloride is a drug product that is used as an impurity standard in the manufacture of 11-aminoundecanoic acid. It is also used to study the metabolism of this compound. This drug product is not intended for use in humans or animals.

Atorvastatin diepoxide is an analytical standard for the drug atorvastatin that is used in the development of pharmaceuticals. It is synthesized by reacting atorvastatin with epichlorohydrin, which produces a diepoxide derivative. This synthetic molecule can be used as an impurity standard for HPLC analysis. The CAS number for atorvastatin diepoxide is 887470-43-1.

Apixaban Impurity 3 is a reactant in medicines. It reacts with an amide to form the target compound, apixaban. Apixaban is a drug used to prevent stroke and blood clots in patients who have atrial fibrillation.

O3-Desethyl apremilast is an experimental drug product that belongs to the class of drug products. This drug product has been shown to be a natural, synthetic and analytical impurity in API. It is also an impurity standard for HPLC analysis. O3-Desethyl apremilast can be used in research and development, as well as niche applications in the pharmaceutical industry.

N,N'''-(Dithia-2,1-ethanediyl)bis-(N'-cyano-N''-methyl)guanidine is a metabolite of guanidine. It is a synthetic compound that is used as an analytical reference standard and impurity in pharmaceutical products. It is also used to create an impurity standard for HPLC analysis. This compound has been found in natural sources such as plants and animal tissues, but it can also be synthesized in the lab. The CAS number for this substance is 74886-59-2.

Rifaximin Impurity 2 is a custom synthesis that is made to the customer's specifications. This compound is used as an impurity standard for drug product. It has a high purity and follows the pharmacopoeia standards. Rifaximin Impurity 2 is used in research and development of new drugs, which includes drug metabolism studies. This compound can be synthesized with natural or synthetic methods, and can be analyzed using HPLC.

N,N'-Bis(4-chlorobenzylidene)hydrazine is an organic nitrogen compound that is used as a reagent in organic chemistry. It can be used to synthesize hydrazones, toluenes, and carbonyls. This reagent also has the ability to catalyze olefinations. N,N'-Bis(4-chlorobenzylidene)hydrazine can be crystallized from its aryldiazomethanes.

This compound is a research and development impurity standard. It is synthesized in accordance with the pharmacopoeia, and it is an API impurity. It is also used as a metabolite standard for drug development and metabolism studies. This compound has been tested in HPLC standards.

Tirzepatide impurities.